AAAP: GOOD NEWS FOR TREATMENT OF THE CANCER THAT KILLED STEVE JOBS OF APPLE $AAPL $AAAP $NVS
This post was just published on ZYX Buy Change Alert. Advanced Accelerator Applications (AAAP) stock is long from $40.50. As of this writing it is trading at $66.65. AAAP’s lutetium, the treatment for the cancer that killed Steve Jobs of Apple (AAPL), has been approved by the European Commission. This good news is on top of the information we shared with you yesterday that Novartis (NVS) is looking at a buyout of AAAP. What To Do Now Those in the stock may continue to hold. Those not in the stock and are super aggressive may consider starting a very, very small position right